[Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
D000368:Aged; D000990:Antithrombin III / Q000032:analysis; D001161:Arteriosclerosis / Q000097:blood*; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D005341:Fibrinolysin / Q000032:analysis / Q000037:antagonists & inhibitors; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood; D000515:alpha 1-Antitrypsin / Q000032:analysis; D000511:alpha-Macroglobulins / Q000032:analysis
D003174:Complement C1 Inactivator Proteins; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D000990:Antithrombin III; D005341:Fibrinolysin